SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-058895
Filing Date
2020-11-17
Accepted
2020-11-17 18:57:06
Documents
2
Period of Report
2020-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2200
2 POA DOCUMENT poa.txt EX-24.3_945575 3759
  Complete submission text file 0001209191-20-058895.txt   7450
Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37345 | Film No.: 201322448

Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Issuer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences